BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9389360)

  • 1. Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma.
    Pinotti G; Zucca E; Roggero E; Pascarella A; Bertoni F; Savio A; Savio E; Capella C; Pedrinis E; Saletti P; Morandi E; Santandrea G; Cavalli F
    Leuk Lymphoma; 1997 Aug; 26(5-6):527-37. PubMed ID: 9389360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stage I and II MALT lymphoma: results of treatment with radiotherapy.
    Tsang RW; Gospodarowicz MK; Pintilie M; Bezjak A; Wells W; Hodgson DC; Crump M
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1258-64. PubMed ID: 11483337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis and therapeutic management of gastric lymphomas].
    Grau E; Perella M; Gómez A; Pastor E; Mirabet MD; García F; Ibáñez JL; Aguiló J
    Sangre (Barc); 1996 Apr; 41(2):109-14. PubMed ID: 9045350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective analysis of primary gastric diffuse large B-cell lymphoma with or without concomitant mucosa-associated lymphoid tissue (MALT) lymphoma components.
    Li X; Xia B; Guo S; Zhan Z; Zhang L; Zhao D; Wu X; Zhang Y
    Ann Hematol; 2013 Jun; 92(6):807-15. PubMed ID: 23417758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Helicobacter pylori infection and gastric MALT lymphoma: present-day approaches to research and treatment].
    Novik AA; Denisov NL; Gershanovich ML; Pozharisskiĭ KM; Gorodokin I
    Vopr Onkol; 2002; 48(3):283-91. PubMed ID: 12455349
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
    Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
    Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan.
    Nakamura S; Sugiyama T; Matsumoto T; Iijima K; Ono S; Tajika M; Tari A; Kitadai Y; Matsumoto H; Nagaya T; Kamoshida T; Watanabe N; Chiba T; Origasa H; Asaka M;
    Gut; 2012 Apr; 61(4):507-13. PubMed ID: 21890816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management and long-term follow-up of early stage H. pylori-associated gastric MALT-lymphoma in clinical practice: an Italian, multicentre study.
    Andriani A; Miedico A; Tedeschi L; Patti C; Di Raimondo F; Leone M; Schinocca L; Romanelli A; Bonanno G; Linea C; Giustini M; Hassan C; Cottone M; Zullo A
    Dig Liver Dis; 2009 Jul; 41(7):467-73. PubMed ID: 18945654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recent progress in the management of malignant lymphoma].
    Ohnishi K
    Gan To Kagaku Ryoho; 1997 Jul; 24(9):1074-8. PubMed ID: 9239159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment.
    Nakamura S; Matsumoto T; Suekane H; Nakamura S; Matsumoto H; Esaki M; Yao T; Iida M
    Cancer; 2005 Aug; 104(3):532-40. PubMed ID: 15937928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-grade MALT lymphoma of the stomach: a review of treatment options.
    Schechter NR; Yahalom J
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1093-103. PubMed ID: 10725618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgery and chemotherapy versus chemotherapy as treatment of high-grade MALT gastric lymphoma.
    Avilés A; Neri N; Nambo MJ; Huerta-Guzman J; Cleto S
    Med Oncol; 2006; 23(2):295-300. PubMed ID: 16720930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Operative and conservative management of primary gastric lymphoma: interim results of a German multicenter study.
    Willich NA; Reinartz G; Horst EJ; Delker G; Reers B; Hiddemann W; Tiemann M; Parwaresch R; Grothaus-Pinke B; Kocik J; Koch P
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):895-901. PubMed ID: 10705011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of non-surgical therapy for the malignant lymphomas located mainly in the stomach and duodenum].
    Tari A; Asaoku H; Tani H; Kashiwado K; Kurihara K; Fujihara M; Yoshino T
    Nihon Shokakibyo Gakkai Zasshi; 2001 Oct; 98(10):1154-63. PubMed ID: 11680989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
    Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL
    J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with Helicobacter pylori negative gastric marginal zone b-cell lymphoma (MZBCL) of MALT have a good prognosis.
    Al-Taie O; Al-Taie E; Fischbach W
    Z Gastroenterol; 2014 Dec; 52(12):1389-93. PubMed ID: 25474277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ongoing monoclonal B-cell proliferation is not common in gastric B-cell lymphoma after combined radiochemotherapy.
    Alpen B; Kuse R; Parwaresch R; Müller-Hermelink HK; Stolte M; Neubauer A
    J Clin Oncol; 2004 Aug; 22(15):3039-45. PubMed ID: 15284253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of gastric marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue with rituximab, cyclophosphamide, vincristine and prednisone.
    Aguiar-Bujanda D; Llorca-Mártinez I; Rivero-Vera JC; Blanco-Sánchez MJ; Jiménez-Gallego P; Mori-De Santiago M; Limeres-Gonzalez MA; Cabrera-Marrero JC; Hernández-Sosa M; Galván-Ruíz S; Hernández-Sarmiento S; Saura Grau S; Bohn-Sarmiento U
    Hematol Oncol; 2014 Sep; 32(3):139-44. PubMed ID: 24123108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab, alkylating agents or combination therapy for gastric mucosa-associated lymphoid tissue lymphoma: a monocentric non-randomised observational study.
    Amiot A; Lévy M; Copie-Bergman C; Dupuis J; Szablewski V; Le Baleur Y; Baia M; Belhadj K; Sobhani I; Leroy K; Haioun C; Delchier JC
    Aliment Pharmacol Ther; 2014 Mar; 39(6):619-28. PubMed ID: 24467480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in the treatment strategy of primary gastric lymphoma].
    Tóth I; Nagy Z; Barna T; Szucs G
    Magy Seb; 2007 Apr; 60(2):79-86. PubMed ID: 17649848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.